Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. (Q40494023)

From Wikidata

Revision as of 02:53, 4 November 2018 by Citationgraph bot 2 (talk | contribs) (‎Updated Item: Updating citation graph)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Ezequiel I Surace

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Eriks Lusis

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Yoshinori Murakami

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bernd W Scheithauer

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

David H Gutmann

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Neuropathology & Experimental Neurology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1015-1027

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Meningioma grading: an analysis of histologic parameters

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

The tumor suppressor protein TSLC1 is involved in cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

RA175, which is the mouse ortholog of TSLC1, a tumor suppressor gene in human lung cancer, is a cell adhesion molecule

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Hypermethylation of the TSLC1 Gene Promoter in Primary Gastric Cancers and Gastric Cancer Cell Lines

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Analysis of the PTEN gene in human meningiomas

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.10.1015

21 January 2018

Identifiers

10.1093/JNEN/63.10.1015

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40494023&oldid=781426521"